Related Experiment Video
Updated: Aug 15, 2026
Pyrosequencing for Microbial Identification and Characterization
Published on: August 22, 2013
Use of resequencing oligonucleotide microarrays for identification of Streptococcus pyogenes and associated
Louis Davignon1, Elizabeth A Walter, Kate M Mueller
1Malcolm Grow Medical Center, Andrews Air Force Base, Maryland 20762, USA.
Abstract:
Group A streptococci (GAS) are responsible for a wide variety of human infections associated with considerable morbidity and mortality. Ever since the first systematic effort by Lancefield to group Streptococcus species by M protein variants, the detection and characterization of Streptococcus by different methods have been an evolving process. The ideal assay for GAS identification not only would provide quick and accurate diagnostic results but also would reveal antibiotic resistance patterns and genotype information, aiding not only in treatment but in epidemiologic assessment as well. The oligonucleotide microarray is a promising new technology which could potentially address this need. In this study, we evaluated the usefulness of oligonucleotide resequencing microarrays for identifying GAS and its associated antibiotic resistance markers. We demonstrated an assay platform that combines the use of resequencing DNA microarrays with either random nucleic acid amplification or multiplex PCR for GAS detection. When detecting Streptococcus pyogenes from coded clinical samples, this approach demonstrated an excellent concordance with a more established culture method. To this end, we showed the potential of resequencing microarrays for efficient and accurate detection of GAS and its associated antibiotic resistance markers with the benefit of sequencing information from microarray analysis.
Insights
Oligonucleotide resequencing microarrays offer a promising method for rapidly identifying Group A Streptococcus (GAS) infections. This technology accurately detects GAS and antibiotic resistance markers, aiding in clinical treatment and epidemiological studies.
Area of Science:
- Microbiology
- Molecular Diagnostics
- Genetics
Background:
- Group A streptococci (GAS) cause significant human infections with high morbidity and mortality.
- Accurate and rapid identification of GAS, along with antibiotic resistance patterns and genotypes, is crucial for effective treatment and epidemiological surveillance.
- Traditional methods for Streptococcus characterization have evolved since Lancefield's initial grouping by M protein variants.
Purpose of the Study:
- To evaluate the utility of oligonucleotide resequencing microarrays for identifying GAS and associated antibiotic resistance markers.
- To demonstrate an assay platform combining resequencing DNA microarrays with nucleic acid amplification or multiplex PCR for GAS detection.
- To assess the accuracy and efficiency of this microarray-based approach compared to established methods.
Main Methods:
- Development of an assay platform utilizing resequencing DNA microarrays.
- Integration of random nucleic acid amplification or multiplex PCR with the microarray platform.
- Testing the assay on coded clinical samples for the detection of Streptococcus pyogenes.
Main Results:
- The oligonucleotide resequencing microarray assay demonstrated excellent concordance with established culture methods for GAS identification.
- The platform successfully identified GAS and associated antibiotic resistance markers.
- Microarray analysis provided valuable sequencing information for GAS characterization.
Conclusions:
- Oligonucleotide resequencing microarrays show significant potential for the efficient and accurate detection of GAS.
- This technology can simultaneously identify antibiotic resistance markers, enhancing clinical and epidemiological insights.
- The developed assay platform offers a valuable tool for rapid and comprehensive GAS diagnostics.
Related Concept Videos
01:29Modern Molecular Taxonomy
01:25Rapid Identification of Pathogens